{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid =  
| IUPAC_name = 4-({[(2''S'',4''S'')-2-[2-(4-Chlorophenyl)ethyl]-2-(1''H''-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl}sulfanyl)aniline
| image = Azalanstat.svg
| width = 275

<!--Clinical data-->
| tradename =
| pregnancy_category =
| legal_status =
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =
| metabolism =
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 143484-82-6
| ATC_prefix = None
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 70611
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C22H24ClN3O2S/c23-18-3-1-17(2-4-18)9-10-22(15-26-12-11-25-16-26)27-13-20(28-22)14-29-21-7-5-19(24)6-8-21/h1-8,11-12,16,20H,9-10,13-15,24H2/t20-,22-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = VYNIUBZKEWJOJP-UNMCSNQZSA-N
| PubChem = 60876
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 54858
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 2NL79NI1WS
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D03025
| synonyms =

<!--Chemical data-->
| C=22 | H=24 | Cl=1 | N=3 | O=2 | S=1 
| molecular_weight = 429.963 g/mol
| smiles = Clc1ccc(cc1)CC[C@@]2(OC[C@H](O2)CSc3ccc(N)cc3)Cn4ccnc4
}}

'''Azalanstat''' ([[International nonproprietary name|INN]],<ref name="INN">{{cite web | title = International Nonproprietary Names for Pharmaceutical Substances (INN). Recommended International Nonproprietary Names (Rec. INN): List 36 | url = http://www.who.int/medicines/publications/druginformation/innlists/RL36.pdf | publisher = World Health Organization | accessdate = 3 January 2017 | page = 141}}</ref> codenamed '''RS-21607''') is an [[Anorectic|anti-obesity drug]] acting as a [[Lanosterol 14 alpha-demethylase|lanosterol 14α-demethylase]] inhibitor.<ref>{{cite journal | last1 = Walker | first1 = KA | last2 = Kertesz | first2 = DJ | last3 = Rotstein | first3 = DM | last4 = Swinney | first4 = DC | last5 = Berry | first5 = PW | last6 = So | first6 = OY | last7 = Webb | first7 = AS | last8 = Watson | first8 = DM | last9 = Mak | first9 = AY | last10 = Burton | first10 = PM | title = Selective Inhibition of Mammalian Lanosterol 14α-Demethylase: A Possible Strategy for Cholesterol Lowering | journal = Journal of Medicinal Chemistry | date = 23 July 1993 | volume = 36 | issue = 15 | pages = 2235–7 | doi = 10.1021/jm00067a022 | pmid = 8340925}}</ref><ref>{{cite journal | last1 = Burton | first1 = PM | last2 = Swinney | first2 = DC | last3 = Heller | first3 = R | last4 = Dunlap | first4 = B | last5 = Chiou | first5 = M | last6 = Malonzo | first6 = E | last7 = Haller | first7 = J | last8 = Walker | first8 = KA | last9 = Salari | first9 = A | last10 = Murakami | first10 = S | title = Azalanstat (RS-21607), a Lanosterol 14α-Demethylase Inhibitor with Cholesterol-Lowering Activity | journal = Biochemical Pharmacology | date = 8 August 1995 | volume = 50 | issue = 4 | pages = 529–44 | pmid = 7646560}}</ref>

==References==
{{reflist}}

{{Antiobesity preparations}}
{{Lipid modifying agents}}

[[Category:Antiobesity drugs]]
[[Category:Chloroarenes]]
[[Category:Dioxolanes]]
[[Category:Hypolipidemic agents]]
[[Category:Imidazoles]]
[[Category:Lanosterol 14α-demethylase inhibitors]]
[[Category:Thioethers]]


{{gastrointestinal-drug-stub}}